药物洗脱球囊治疗颈动脉支架植入后支架内再狭窄进展  

Advancements for treating restenosis after carotid artery stent implantation with drug-eluting balloon

作　　者：郝家伟 鄂亚军[1] 郭东方 彭伟 李志强[1] HAO Jiawei;E Yajun;GUO Dongfang;PENG Wei;LI Zhiqiang(Department of Interventional Radiology & Vascular Surgery, the Affiliated Hospital of Hebei University, Baoding 071000, China)

机构地区：[1]河北大学附属医院介入血管外科,河北保定071000

出　　处：《中国介入影像与治疗学》2022年第4期245-248,共4页Chinese Journal of Interventional Imaging and Therapy

基　　金：河北省重点研发计划项目(182777106D)。

摘　　要：颈动脉狭窄患者接受颈动脉支架(CAS)植入术后可发生支架内再狭窄(ISR),发生率约5%~20%;药物洗脱球囊(DEB)技术用于治疗CAS植入后再狭窄已取得显著成效。本文对DEB治疗CAS植入术后ISR研究进展进行综述。In-stent restenosis(ISR)can occur in patients with carotid artery stenosis after carotid artery stenting(CAS),with the incidence rate of about 5%-20%.Drug-eluting balloon(DEB)technology has achieved remarkable results in treatment of carotid artery restenosis after stent implantation.The advancements of treating ISR after CAS with DEB were reviewed in this article.

关 键 词：颈动脉狭窄 支架 药物洗脱球囊 血管内治疗 

分 类 号：R543.5[医药卫生—心血管疾病] R815[医药卫生—内科学]